Literature DB >> 23775740

Gene-specific PCR typing of killer cell immunoglobulin-like receptors.

Raja Rajalingam1, Elham Ashouri.   

Abstract

By interacting with specific HLA class I molecules, the killer cell immunoglobulin-like receptors (KIR) regulate the effector function of natural killer (NK) cells and subsets of CD8 T cells. The KIR receptors and HLA class I ligands are encoded by unlinked polymorphic gene families located on different human chromosomes, 19 and 6, respectively. The number and type of KIR genes are substantially variable between individuals, which may contribute to human diversity in responding to infection, malignancy and allogeneic transplants. PCR typing using sequence-specific primers (PCR-SSP) is the most commonly used method to determine KIR gene content. This chapter describes a step-by-step protocol for PCR-SSP typing to identify the presence and absence of all 16 known KIR genes. Moreover, the chapter provides the basic rules to verify the accuracy of KIR genotyping results and explains specific methods for the data analysis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775740     DOI: 10.1007/978-1-62703-493-7_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.

Authors:  Ralph D Levinson; Madeline Yung; Akira Meguro; Elham Ashouri; Fei Yu; Nobuhisa Mizuki; Shigeaki Ohno; Raja Rajalingam
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

2.  Paternal HLA-C and Maternal Killer-Cell Immunoglobulin-Like Receptor Genotypes in the Development of Autism.

Authors:  Moriya Gamliel; Karen L Anderson; Richard P Ebstein; Nurit Yirmiya; David Mankuta
Journal:  Front Pediatr       Date:  2016-07-28       Impact factor: 3.418

3.  Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma.

Authors:  Haibo Sun; Thomas G Martin; John Marra; Denice Kong; Jonathon Keats; Sandrine Macé; Marielle Chiron; Jeffrey L Wolf; Jeffrey M Venstrom; Raja Rajalingam
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.